Pletal Related Clinical Trials
Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg [Completed]
Evaluation of Cilostazol in Combination With L-Carnitine [Recruiting]
Cilostazol Augmentation Study in Dementia [Recruiting]
A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus [Recruiting]
Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety [Recruiting]
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage [Recruiting]
Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness [Recruiting]
Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler [Recruiting]
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention [Not yet recruiting]
Sufficient Treatment of Peripheral Intervention by Cilostazol [Recruiting]
Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy [Recruiting]
Effect of Cilostazol on the Pharmacokinetics of Simvastatin [Recruiting]
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon [Completed]
Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon [Completed]
Post-Marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) [Active, not recruiting]
Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina [Recruiting]
Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism [Not yet recruiting]
Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients [Recruiting]
Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After BioMatrix Stent Implantation [Recruiting]
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions [Recruiting]
The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) [Recruiting]
Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events [Recruiting]
A Mono-Center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions [Not yet recruiting]
Cilostazol in Acute Ischemic Stroke Treatment (CAIST) [Active, not recruiting]
The Efficacy of CILostazol ON Thrombotic Complications After DES Implantation [Recruiting]
Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject [Recruiting]
A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy [Recruiting]
Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke [Completed]
Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions [Completed]
Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions [Completed]
Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo [Active, not recruiting]
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker [Recruiting]
Overcome Biochemical Aspirin Resistane Through Cilostazol Combination [Recruiting]
Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease [Completed]
The Use of Cilostazol in Patients With Diabetic Nephropathy [Recruiting]
Efficacy and Safety of Cilostazol for the Indication of CSPS [Recruiting]
Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis [Recruiting]
Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI) [Recruiting]
Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II [Recruiting]
Fasted Bioavailability Study of Cilostazol Tablets, 50mg [Completed]
Fasted Bioavailability Study of Cilostazol Tablets, 100 mg [Completed]
Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent [Recruiting]
The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol [Recruiting]
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients [Recruiting]
Safety and Pharmacokinetics of Probucol and Cilostazol [Recruiting]
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation [Recruiting]
ACCEL-LOADING-ACS Study [Recruiting]
Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation [Completed]
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III) [Recruiting]
Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) [Recruiting]
Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease [Not yet recruiting]
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention [Recruiting]
Efficacy of Self-Expanding Nitinol S.M.A.R.T-CONTROL Stent Versus Complete SE Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease [Not yet recruiting]
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen [Recruiting]
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication [Recruiting]
Mixed Antagonist of Serotonin for Claudication Optimal Therapy [Completed]
Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease [Active, not recruiting]
A Multicenter, Therapeutic Used Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease [Not yet recruiting]
Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease [Recruiting]
|
